NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Six Flags Entertainment Corporation ("Six Flags Entertainment Corporation") (NYSE:FUN) concerning possible violations of federal securities laws. On August 6, 2025, Six Flags issued a press release announcing disappointing second quarter fiscal 2025 […]

NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeMD, Inc. ("LifeMD, Inc.") (NASDAQ:LFMD) concerning possible violations of federal securities laws. LifeMD announced its second quarter 2025 results on August 5, 2025. Among other items, the Company revealed that higher customer

Trading resumes in: Company: BWR EXPLORATION INC. TSX-Venture Symbol: BWR All Issues: Yes Resumption (ET): 8:00 AM 8/25/2025 CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization

B. Riley Financial, Inc. (Nasdaq:RILY) (the “Company”) today announced it received an expected delinquency notification letter from Nasdaq on August 20, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company's Form 10-Q for the period ended June 30, 2025.

(TSX:APS),(Pinksheets:APTOF),(PinkSheets:APTOF), SAN DIEGO and TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), announced the results of its reconvened annual and special

Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor Aptose also Receives Additional Advance from Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML GlobeNewswire August 22, 2025 SAN DIEGO and TORONTO, Aug. 22, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences

AllianceBernstein Holding L.P. (“AB Holding”) (NYSE: AB) today announced that its 2024 Schedule K-3, reflecting items of international tax relevance, is now available for download online. AB unitholders requiring this information may access their Schedules K-3 at www.taxpackagesupport.com/ab. A limited number of unitholders (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax

New research led by the Institute for Iterative Thinking (IFIT) and co-authored by Fresh Tri CEO Dr. Kyra Bobinet reveals a unique, measurable psychological framework that supports sustainable wellbeing and behavior change. Fresh Tri, a neuroscience-backed behavior change company, has just announced the publication of a research paper in the peer-reviewed journal, Behavioral Sciences, detailing

Phone protection is important due to the inevitable drops, scratches, and cracks of everyday life. But what if your phone case could protect more than just your device? CASEKOO's phone cases offer the perfect blend of durability and sustainability-protecting your health by containing less than 0.1% SVHCs and supporting the climate by offsetting carbon emissions,

(NYSE:BBWI), COLUMBUS, Ohio, Aug. 22, 2025 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) announced today that Daniel Heaf, chief executive officer and Eva Boratto, chief financial officer, will participate in a fireside chat at the Goldman Sachs 32nd Annual Global Retailing conference on Wednesday, September 3, 2025, at 8:55 a.m. ET. A